The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches
Open Access
- 19 December 2008
- journal article
- review article
- Published by Springer Nature in Heart Failure Reviews
- Vol. 15 (2) , 121-124
Abstract
This review evaluates the hypothesis that the cardiac effects of amiodarone can be explained—at least partly—by the induction of a local ‘hypothyroid-like condition’ in the heart. Evidence supporting the hypothesis comprises the observation that amiodarone exerts an inhibitory effect on the binding of T3 to thyroid hormone receptors (TR) alpha-1 and beta-1 in vitro, and on the expression of particular T3-dependent genes in vivo. In the heart, amiodarone decreases heart rate and alpha myosin heavy chain expression (mediated via TR alpha-1), and increases sarcoplasmic reticulum calcium-activated ATPase and beta myosin heavy chain expression (mediated via TR beta-1). Recent data show a significant similarity in expression profiles of 8,435 genes in the heart of hypothyroid and amiodarone-treated animals, although similarities do not always exist in transcripts of ion channel genes. Induction of a hypothyroid cardiac phenotype by amiodarone may be advantageous by decreasing energy demands and increasing energy availability.Keywords
This publication has 28 references indexed in Scilit:
- Thyroid hormone and “cardiac metamorphosis”: Potential therapeutic implicationsPharmacology & Therapeutics, 2008
- Thyroid Disease and the HeartCirculation, 2007
- Dronedarone for Maintenance of Sinus Rhythm in Atrial Fibrillation or FlutterNew England Journal of Medicine, 2007
- Effect of amiodarone and dronedarone administration in rats on thyroid hormone-dependent gene expression in different cardiac componentsEuropean Journal of Endocrinology, 2007
- Dronedarone Administration Prevents Body Weight Gain and Increases Tolerance of the Heart to Ischemic Stress: A Possible Involvement of Thyroid Hormone Receptor α 1Thyroid®, 2005
- Long-Term Amiodarone Administration Remodels Expression of Ion Channel Transcripts in the Mouse HeartCirculation, 2004
- Microarray Analysis Reveals Complex Remodeling of Cardiac Ion Channel Expression With Altered Thyroid StatusCirculation Research, 2003
- Desethylamiodarone interferes with the binding of co‐activator GRIP‐1 to the β1‐thyroid hormone receptorFEBS Letters, 2000
- Desethylamiodarone is a competitive inhibitor of the binding of thyroid hormone to the thyroid hormone α1-receptor proteinMolecular and Cellular Endocrinology, 1995
- Desethylamiodarone is a noncompetitive inhibitor of the binding of thyroid hormone to the thyroid hormone beta 1-receptor proteinEndocrinology, 1994